Shotlee LogoShotlee
Blog
Download on theApp Store
Become aBeta Tester
Skip to main content
Brooks Nader Discloses Cosmetic Surgeries and GLP-1 Usage for Career Growth - Featured image
Health & Beauty

Brooks Nader Discloses Cosmetic Surgeries and GLP-1 Usage for Career Growth

Model Brooks Nader has openly discussed her cosmetic surgery history and GLP-1 usage, citing career benefits. The 28-year-old detailed various procedures and weight loss methods, highlighting the pressures within the fashion industry.

Shotlee·November 6, 2025·Updated Jan 27, 2026·2 min read
Share:

Brooks Nader Discloses Cosmetic Surgeries and GLP-1 Usage for Career Growth

Sports Illustrated model Brooks Nader has openly discussed her extensive history with cosmetic surgery. In a recent interview, the 28-year-old model shared details with Bustle. Nader revealed information about procedures such as a nose job, veneers, and numerous injectable treatments. She also confirmed her use of GLP-1 weight loss medication.

Her statements underscore the intense pressures faced by models within the fashion industry. Nader directly connected her physical transformations to increased opportunities in her career. She acknowledged the problematic standards without offering any apologies.

Nader admitted to undergoing rhinoplasty, although she mentioned that some now say she resembles Michael Jackson. Furthermore, she received veneers and a multitude of injectable treatments. These include salmon sperm facials and the “Nefertiti” Botox neck lift.

Track your medication journey

Join thousands using Shotlee to track GLP-1 medications.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Become aBeta Tester

The model made light of her frequent procedures. She joked that every Christmas leaves her looking like Freddy Krueger during recovery. Despite acknowledging the industry's inherent unfairness, Nader maintains a practical perspective on beauty expectations. She considers these modifications essential tools for career advancement in a competitive environment. Health tracking apps like Shotlee can help monitor changes after such procedures.

Nader was equally candid regarding her use of GLP-1 for weight management. She recalled receiving direct feedback from her agency about the need to lose thirty pounds. Nader addressed this as a practical issue to resolve, rather than reacting emotionally. Her focus was on achieving the required physical transformation.

The model stated clearly that her career saw significant acceleration after she began using GLP-1 medication. After losing weight, she booked a notably higher number of jobs. Nader emphasized that she is not endorsing the industry's standards. She simply reported what proved effective for her professionally within the existing market.

Original source: Bangla news

View original article →
#Brooks Nader#cosmetic surgery#GLP-1#weight loss#model#career#fashion industry
  1. Home
  2. Blog
  3. Brooks Nader Discloses Cosmetic Surgeries and GLP-1 Usage for Career Growth

Related Articles

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations
GLP-1 Medications

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations

Midlife weight gain is hitting millennial stars hard, but many are turning to Ozempic and other GLP-1s for help. Celebrities including Amy Schumer, Golnesa 'GG' Gharachedaghi, and Serena Williams have openly admitted to using these medications, sharing their triumphs, side effects, and transformations. Discover their stories and the science behind these popular drugs.

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds
GLP-1 Medications

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds

New research uncovers potential effects of SNAC—the hidden ingredient enabling Ozempic and Wegovy tablets—on gut health. In a 21-day animal study, repeated exposure led to shifts in harmful gut bacteria, elevated inflammation, and depleted cognitive proteins. While not proving harm in humans, findings urge caution as oral semaglutide use surges.

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report
Metabolic Health

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report

Urban India faces a metabolic crisis with 73 million overweight adults, yet GLP-1 therapy awareness hovers below 5%, per Kantar's latest report. Despite high weight loss intent, a stark knowledge gap limits adoption of these diabetes and obesity treatments. Explore the data, demographics, and paths forward for better metabolic health.

Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Get Started

Resources

  • Health Blog
  • Support Center
  • System Status

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with ♥ for the community